1

13

c

Figure 1.3

ug/mg creatinine

mg/L

2

19

c

Table 2.1 (For consistency among other sections)

19

-

- Vitamin B3 (Niacin)

50–3000 mg

100–1000 mg

19

-

- Folate

5–150 mg

200–800 mg

19

- 

- Coenzyme Q10

10–3000 mg

10–300 mg

19

- 

- Choline

1–12 g

1–2 g

24

c

Col 1, top, “Adult repletion:”

50 to 200 mg/d

50 to 300 mg/d

42

c

Figure 2.14

Previtamin D structure

See PDF

3

67

c

Table 3.1, Vanadium, dosage

9 µg–125 mg
(as vanadyl sulfate)

9–250 µg

116

t

First sentence

200–100 mg

200–1000 mg

118

c

Col 2, Vanadium, dosage

9 µg–125 mg

9–250 µg

119

c

Table 3.8, reference number in title

666

673

131

c

Last paragraph, references

837 and 838

838 and 837

167

c

Reference 673

(Vol & pages missing)

;26(2):193-207.

167

t

Reference 695

Novermber

November

4

201

c

Figure 4.11, shaded green box

(Missing text)

ADMA – Asymmetric Dimethylarginine
PRMT – Protein arginine methyl transferase
DDAH – Dimethylarginine dimethylaminohydrolase
NOS – Nitric oxide synthase

207

t

Figure 4.12, top

Branch-chain

Branched-chain

231

t

Figure 4.22

Phosphotidyl choline

Phosphatidyl choline

231

c

Figure 4.22

(Missing arrow)

An arrow pointing from Phosphoethanolamine to Phosphatidyl choline

234

t

Figure 4.24

Sacosine dehydrogenase

Sarcosine dehydrogenase

241

c

Col 2, paragraph 2, last sentence

β-alanine is

β-alanine, are

5

284

t

Figure 5.9, “Peroxisome”

22:6n5

22:6n3

286

t

Figure 5.10

Eicosapentaente

Dihomogammalinnoleate

Eicosapentaenoate

Dihomogammalinnolenate

6

322

c

Table 6.1, Fumarate

(omitted entry for High result)

CoQ10, 50 mg TID, magnesium 500 mg

356

c

Figure 6.14, 1^st reaction

(omitted reactant)

Add superoxide (O₂•)

357

c

Figure 6.15 A, metabolic intermediates out of order

3-Hydroxyanthranilate → 3-Hydroxykynurenate

3-Hydroxykynurenin → 3-Hydroxyanthranilate

361

c

Structure of 8-OHdG

(Ring substituents)

See structure on page 530

372-373

c

Table 6.11 (reference numbers incorrect, except for No. 13)

Entire sequence from 409 through 422

Sequentially replace with 459 through 472 (See page 409)

373

c

Table 6.11

406

455 (See page 409)

376

t

Figure 6.26, caption, 3^rd line

causes

cause

376

t

Figure 6.26, caption, 3^rd line

Abnomally

Abnormally

379

c

Figure 6.28

(Missing citation)

Add reference: 517

386

t

Table 6.15 title

D-Lactate

Lactate

388

t

Col 1, line 8

normal DAl levels

normal DA levels

410

c

Reference 508

Machino H, Miki Y, Kawatsu T, et al. Successful dietary control of tyrosinemia II. J Am Acad Dermatol. 1983;9(4):533-539.

Uribarri J, Oh MS Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998;77(2):73-82.

8

480-481, and 508

c

References for the citations in the “Phthalates” section were omitted, and the citation numbers were used redundantly on pages 481–2 and in Figure 8.7.

References 64–73 on page 508 are for the citations on pages 481–2.

A label containing the references for the “Phthalates” section was pasted onto page 512. (Corrections to the references were made in the CD version included with the book.)

496

t

Table 1.18, under “Xenobiotics / Glycine Conjugation”

Alphatic

Aliphatic